The global tuberculosis burden remains substantial, with more than 10 million people newly
ill per year. Nevertheless, tuberculosis incidence has slowly declined over the past decade …

Introduction Pulmonary tuberculosis (TB) is an important risk factor for chronic respiratory
disease due to residual lung damage. Yet, the WHO End TB strategy does not mention post …

Background Post-tuberculosis lung damage (PTLD) is a recognised consequence of
pulmonary TB (pTB). However, little is known about its prevalence, patterns and associated …

Setting The study was conducted at Mulago Hospital, Kampala, Uganda. Objective As
chronic respiratory disease (CRD) is a huge, growing burden in Africa, with few available …

Tuberculosis (TB) is one of the top ten leading causes of death worldwide. The causative
agent of TB is Mycobacterium tuberculosis. Acute tuberculous pneumonia (TP) is an acute …

Objectives Pulmonary function impairment and chronic respiratory symptoms after
tuberculosis are relatively common in low-income and middle-income countries. We aimed …

Background The Xpert MTB/RIF (Xpert) assay offers rapid and accurate diagnosis of
tuberculosis (TB) but still suffers from imperfect sensitivity. The newer Xpert MTB/RIF Ultra …

The intersection of tuberculosis (TB) with non-communicable diseases (NCDs), including
diabetes mellitus (DM), chronic lung disease (CLD), and cardiovascular disease (CVD), has …

Background Pulmonary tuberculosis (PTB) is a risk factor for COPD, but the clinical
characteristics and the chest imaging features (emphysema and bronchiectasis) of COPD …

Background A high risk of tuberculosis (TB), chronic lung disease, and mortality have been
reported among people with a history of previous TB treatment, but data from high-incidence …